Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit

Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminde...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohaghegh, Fatemeh, Hatami, Parvaneh, Aryanian, Zeinab, Fatemi, Farahnaz, Mohseni Afshar, Zeinab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385380/
https://www.ncbi.nlm.nih.gov/pubmed/35991338
http://dx.doi.org/10.1155/2022/9880827
_version_ 1784769579923275776
author Mohaghegh, Fatemeh
Hatami, Parvaneh
Aryanian, Zeinab
Fatemi, Farahnaz
Mohseni Afshar, Zeinab
author_facet Mohaghegh, Fatemeh
Hatami, Parvaneh
Aryanian, Zeinab
Fatemi, Farahnaz
Mohseni Afshar, Zeinab
author_sort Mohaghegh, Fatemeh
collection PubMed
description Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.
format Online
Article
Text
id pubmed-9385380
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93853802022-08-18 Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit Mohaghegh, Fatemeh Hatami, Parvaneh Aryanian, Zeinab Fatemi, Farahnaz Mohseni Afshar, Zeinab Case Rep Med Case Report Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients. Hindawi 2022-08-10 /pmc/articles/PMC9385380/ /pubmed/35991338 http://dx.doi.org/10.1155/2022/9880827 Text en Copyright © 2022 Fatemeh Mohaghegh et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mohaghegh, Fatemeh
Hatami, Parvaneh
Aryanian, Zeinab
Fatemi, Farahnaz
Mohseni Afshar, Zeinab
Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit
title Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit
title_full Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit
title_fullStr Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit
title_full_unstemmed Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit
title_short Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit
title_sort acute generalized exanthematous pustulosis following sars-cov-2 virus: remdesivir as a suspected culprit
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385380/
https://www.ncbi.nlm.nih.gov/pubmed/35991338
http://dx.doi.org/10.1155/2022/9880827
work_keys_str_mv AT mohagheghfatemeh acutegeneralizedexanthematouspustulosisfollowingsarscov2virusremdesivirasasuspectedculprit
AT hatamiparvaneh acutegeneralizedexanthematouspustulosisfollowingsarscov2virusremdesivirasasuspectedculprit
AT aryanianzeinab acutegeneralizedexanthematouspustulosisfollowingsarscov2virusremdesivirasasuspectedculprit
AT fatemifarahnaz acutegeneralizedexanthematouspustulosisfollowingsarscov2virusremdesivirasasuspectedculprit
AT mohseniafsharzeinab acutegeneralizedexanthematouspustulosisfollowingsarscov2virusremdesivirasasuspectedculprit

Ejemplares similares